Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Metabolic Brain Disease
Metadata
Title
Author Index to Volume 17 (2002)
Publication date
01-12-2002
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Metabolic Brain Disease / Issue 4/2002
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1023/A:1021964520793

Other articles of this Issue 4/2002

Metabolic Brain Disease 4/2002 Go to the issue

OriginalPaper

Altered Modulation of Soluble Guanylate Cyclase by Nitric Oxide in Patients with Liver Disease

Preface

Preface

OriginalPaper

Ammonia, the GABA Neurotransmitter System, and Hepatic Encephalopathy

OriginalPaper

Bioartificial Liver Support Anno 2001

OriginalPaper

Increased Extracellular Brain Glutamate in Acute Liver Failure: Decreased Uptake or Increased Release?

OriginalPaper

Clinical Efficacy of L-Ornithine–L-Aspartate in the Management of Hepatic Encephalopathy